These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15911273)

  • 1. A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
    Tobita M; Nishikawa T; Nagashima R
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2886-90. PubMed ID: 15911273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Support vector machines classification of hERG liabilities based on atom types.
    Jia L; Sun H
    Bioorg Med Chem; 2008 Jun; 16(11):6252-60. PubMed ID: 18448342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines.
    Kupershmidt S; Yang IC; Hayashi K; Wei J; Chanthaphaychith S; Petersen CI; Johns DC; George AL; Roden DM; Balser JR
    FASEB J; 2003 Dec; 17(15):2263-5. PubMed ID: 14525949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flunarizine is a highly potent inhibitor of cardiac hERG potassium current.
    Trepakova ES; Dech SJ; Salata JJ
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):211-20. PubMed ID: 16495758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline.
    Teschemacher AG; Seward EP; Hancox JC; Witchel HJ
    Br J Pharmacol; 1999 Sep; 128(2):479-85. PubMed ID: 10510461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The low-potency, voltage-dependent HERG blocker propafenone--molecular determinants and drug trapping.
    Witchel HJ; Dempsey CE; Sessions RB; Perry M; Milnes JT; Hancox JC; Mitcheson JS
    Mol Pharmacol; 2004 Nov; 66(5):1201-12. PubMed ID: 15308760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hERG classification model based on a combination of support vector machine method and GRIND descriptors.
    Li Q; Jørgensen FS; Oprea T; Brunak S; Taboureau O
    Mol Pharm; 2008; 5(1):117-27. PubMed ID: 18197627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
    Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
    J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o.
    Diaz GJ; Daniell K; Leitza ST; Martin RL; Su Z; McDermott JS; Cox BF; Gintant GA
    J Pharmacol Toxicol Methods; 2004; 50(3):187-99. PubMed ID: 15519905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated tight seal electrophysiology for assessing the potential hERG liability of pharmaceutical compounds.
    Tao H; Santa Ana D; Guia A; Huang M; Ligutti J; Walker G; Sithiphong K; Chan F; Guoliang T; Zozulya Z; Saya S; Phimmachack R; Sie C; Yuan J; Wu L; Xu J; Ghetti A
    Assay Drug Dev Technol; 2004 Oct; 2(5):497-506. PubMed ID: 15671647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lidoflazine is a high affinity blocker of the HERG K(+)channel.
    Ridley JM; Dooley PC; Milnes JT; Witchel HJ; Hancox JC
    J Mol Cell Cardiol; 2004 May; 36(5):701-5. PubMed ID: 15135665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death.
    De Bruin ML; Pettersson M; Meyboom RH; Hoes AW; Leufkens HG
    Eur Heart J; 2005 Mar; 26(6):590-7. PubMed ID: 15637086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APETx1, a new toxin from the sea anemone Anthopleura elegantissima, blocks voltage-gated human ether-a-go-go-related gene potassium channels.
    Diochot S; Loret E; Bruhn T; Béress L; Lazdunski M
    Mol Pharmacol; 2003 Jul; 64(1):59-69. PubMed ID: 12815161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization.
    Moreno I; Caballero R; González T; Arias C; Valenzuela C; Iriepa I; Gálvez E; Tamargo J; Delpón E
    J Pharmacol Exp Ther; 2003 Feb; 304(2):862-73. PubMed ID: 12538844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of levobupivacaine, ropivacaine and bupivacaine on HERG channels: stereoselective bupivacaine block.
    González T; Arias C; Caballero R; Moreno I; Delpón E; Tamargo J; Valenzuela C
    Br J Pharmacol; 2002 Dec; 137(8):1269-79. PubMed ID: 12466236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.
    Kang J; Chen XL; Wang H; Ji J; Cheng H; Incardona J; Reynolds W; Viviani F; Tabart M; Rampe D
    Mol Pharmacol; 2005 Mar; 67(3):827-36. PubMed ID: 15548764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of hERG potassium channel blockage using ensemble learning methods and molecular fingerprints.
    Liu M; Zhang L; Li S; Yang T; Liu L; Zhao J; Liu H
    Toxicol Lett; 2020 Oct; 332():88-96. PubMed ID: 32629073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability in the measurement of hERG potassium channel inhibition: effects of temperature and stimulus pattern.
    Kirsch GE; Trepakova ES; Brimecombe JC; Sidach SS; Erickson HD; Kochan MC; Shyjka LM; Lacerda AE; Brown AM
    J Pharmacol Toxicol Methods; 2004; 50(2):93-101. PubMed ID: 15385083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a high-throughput fluorescence assay method for HERG potassium channel inhibition.
    Dorn A; Hermann F; Ebneth A; Bothmann H; Trube G; Christensen K; Apfel C
    J Biomol Screen; 2005 Jun; 10(4):339-47. PubMed ID: 15964935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altering extracellular potassium concentration does not modulate drug block of human ether-a-go-go-related gene (hERG) channels.
    Limberis JT; Su Z; Cox BF; Gintant GA; Martin RL
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1059-65. PubMed ID: 17042915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.